Fibroblast Heterogeneity and Immunosuppressive Environment in Human Breast Cancer.

Carcinoma-associated fibroblasts (CAF) are key players in the tumor microenvironment. Here, we characterize four CAF subsets in breast cancer with distinct properties and levels of activation. Two myofibroblastic subsets (CAF-S1, CAF-S4) accumulate differentially in triple-negative breast cancers (TNBC). CAF-S1 fibroblasts promote an immunosuppressive environment through a multi-step mechanism. By secreting CXCL12, CAF-S1 attracts CD4+CD25+ T lymphocytes and retains them by OX40L, PD-L2, and JAM2. Moreover, CAF-S1 increases T lymphocyte survival and promotes their differentiation into CD25HighFOXP3High, through B7H3, CD73, and DPP4. Finally, in contrast to CAF-S4, CAF-S1 enhances the regulatory T cell capacity to inhibit T effector proliferation. These data are consistent with FOXP3+ T lymphocyte accumulation in CAF-S1-enriched TNBC and show how a CAF subset contributes to immunosuppression.

[1]  James O. Jones,et al.  Suppression of Antitumor Immunity by Stromal Cells Expressing , 2022 .

[2]  V. Mieulet,et al.  Heterogeneity in Cancer Metabolism: New Concepts in an Old Field , 2017, Antioxidants & redox signaling.

[3]  Derek S. Chan,et al.  Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti–PD-L1 immunotherapy in pancreatic cancer , 2013, Proceedings of the National Academy of Sciences.

[4]  Bin Zhang.  CD73: a novel target for cancer immunotherapy. , 2010, Cancer research.

[5]  A. Vincent-Salomon,et al.  Oxidative stress promotes myofibroblast differentiation and tumour spreading , 2010, EMBO molecular medicine.

[6]  N. Ohuchi,et al.  Stromal expression of fibroblast activation protein/seprase, a cell membrane serine proteinase and gelatinase, is associated with longer survival in patients with invasive ductal carcinoma of breast , 2001, International journal of cancer.

[7]  R. Weinberg,et al.  Malignant transformation of mouse primary keratinocytes by Harvey sarcoma virus and its modulation by surrounding normal cells. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[8]  D. Fearon.  The Carcinoma-Associated Fibroblast Expressing Fibroblast Activation Protein and Escape from Immune Surveillance , 2014, Cancer Immunology Research.

[9]  Helen H. W. Chen,et al.  Expression of S100A4 and Met: Potential Predictors for Metastasis and Survival in Early-Stage Breast Cancer , 2004, Oncology.

[10]  D. Dimitrov,et al.  Eradication of Tumors through Simultaneous Ablation of CD276/B7-H3-Positive Tumor Cells and Tumor Vasculature. , 2017, Cancer cell.

[11]  Xiao-Jun Ma,et al.  Gene expression profiling of the tumor microenvironment during breast cancer progression , 2009, Breast Cancer Research.

[12]  Howard Y. Chang,et al.  Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[13]  R. Tibshirani,et al.  Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[14]  V. Speirs,et al.  Clinical and functional significance of loss of caveolin‐1 expression in breast cancer‐associated fibroblasts , 2012, The Journal of pathology.

[15]  M. Delorenzi,et al.  Identification of Prognostic Molecular Features in the Reactive Stroma of Human Breast and Prostate Cancer , 2011, PloS one.

[16]  John Quackenbush,et al.  Characterization and Clinical Evaluation of CD10+ Stroma Cells in the Breast Cancer Microenvironment , 2012, Clinical Cancer Research.

[17]  G. Freeman,et al.  PD-L2 is a second ligand for PD-1 and inhibits T cell activation , 2001, Nature Immunology.

[18]  M. Mcnamara,et al.  OX40 Agonists and Combination Immunotherapy: Putting the Pedal to the Metal , 2015, Front. Oncol..

[19]  R. West,et al.  Next generation sequencing-based expression profiling identifies signatures from benign stromal proliferations that define stromal components of breast cancer , 2013, Breast Cancer Research.

[20]  F. Pépin,et al.  Stromal gene expression predicts clinical outcome in breast cancer , 2008, Nature Medicine.

[21]  Umar Mahmood,et al.  Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival. , 2014, Cancer cell.

[22]  H. Ertl,et al.  Depletion of FAP+ cells reduces immunosuppressive cells and improves metabolism and functions CD8+T cells within tumors , 2016, Oncotarget.

[23]  Z. Ou,et al.  Effects of ecto-5'-nucleotidase on human breast cancer cell growth in vitro and in vivo. , 2007, Oncology reports.

[24]  Jingqin Luo,et al.  Stromal senescence establishes an immunosuppressive microenvironment that drives tumorigenesis , 2016, Nature Communications.

[25]  J. Winstanley,et al.  Prognostic significance of the metastasis-inducing protein S100A4 (p9Ka) in human breast cancer. , 2000, Cancer research.

[26]  F. Mechta-Grigoriou,et al.  The role of reactive oxygen species and metabolism on cancer cells and their microenvironment. , 2014, Seminars in cancer biology.

[27]  Raghu Kalluri,et al.  Fibroblasts in cancer , 2006, Nature Reviews Cancer.

[28]  Janna Paulsson,et al.  PDGF receptors in tumor biology: prognostic and predictive potential. , 2014, Future oncology.

[29]  P. Gascard,et al.  Carcinoma-associated fibroblasts: orchestrating the composition of malignancy , 2016, Genes & development.

[30]  Dennis C. Sgroi,et al.  Stromal Fibroblasts Present in Invasive Human Breast Carcinomas Promote Tumor Growth and Angiogenesis through Elevated SDF-1/CXCL12 Secretion , 2005, Cell.

[31]  A. Giuliano,et al.  B7–H3 Ligand Expression by Primary Breast Cancer and Associated With Regional Nodal Metastasis , 2010, Annals of surgery.

[32]  Peter Olson,et al.  Cancer-Associated Fibroblasts Are Activated in Incipient Neoplasia to Orchestrate Tumor-Promoting Inflammation in an NF-kappaB-Dependent Manner. , 2010, Cancer cell.

[33]  E. Sonnhammer,et al.  Prognostic significance in breast cancer of a gene signature capturing stromal PDGF signaling. , 2013, The American journal of pathology.

[34]  K. Sugamura,et al.  Distinct Roles for the OX40-OX40 Ligand Interaction in Regulatory and Nonregulatory T Cells1 , 2004, The Journal of Immunology.

[35]  J. Taube,et al.  Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy , 2016, Nature Reviews Cancer.

[36]  Matthew L Albert,et al.  Dipeptidylpeptidase 4 inhibition enhances lymphocyte trafficking, improving both naturally occurring tumor immunity and immunotherapy , 2015, Nature Immunology.

[37]  B. Fox,et al.  Signaling through OX40 enhances antitumor immunity. , 2010, Seminars in oncology.

[38]  Z. Werb,et al.  Targeting the cancer-associated fibroblasts as a treatment in triple-negative breast cancer , 2016, Oncotarget.

[39]  Eva C. Arnspang,et al.  Anti-Human CD73 Monoclonal Antibody Inhibits Metastasis Formation in Human Breast Cancer by Inducing Clustering and Internalization of CD73 Expressed on the Surface of Cancer Cells , 2013, The Journal of Immunology.

[40]  Hans Clevers,et al.  Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer , 2017, The Journal of experimental medicine.

[41]  F M Blows,et al.  Association between CD8+ T-cell infiltration and breast cancer survival in 12,439 patients. , 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

[42]  H. Friess,et al.  B7-H3 and Its Role in Antitumor Immunity , 2010, Clinical & developmental immunology.

[43]  L. Ouafik,et al.  Stromal fibroblasts present in breast carcinomas promote tumor growth and angiogenesis through adrenomedullin secretion , 2017, Oncotarget.

[44]  Stefano Tarantola,et al.  Sensitivity Analysis in Practice: A Guide to Assessing Scientific Models , 2004 .

[45]  J. Cheng,et al.  Tumour-infiltrating regulatory T cells stimulate mammary cancer metastasis through RANKL–RANK signalling , 2011, Nature.

[46]  T. Golub,et al.  Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion , 2012, Nature.

[47]  Sean C. Bendall,et al.  Extracting a Cellular Hierarchy from High-dimensional Cytometry Data with SPADE , 2011, Nature Biotechnology.

[48]  Yuli Lin,et al.  FAP Promotes Immunosuppression by Cancer-Associated Fibroblasts in the Tumor Microenvironment via STAT3-CCL2 Signaling. , 2016, Cancer research.

[49]  Drew M. Pardoll,et al.  The blockade of immune checkpoints in cancer immunotherapy , 2012, Nature Reviews Cancer.

[50]  A. Tsapas,et al.  Safety of dipeptidyl peptidase 4 inhibitors: a perspective review , 2014, Therapeutic advances in drug safety.

[51]  Piero Carninci,et al.  A draft network of ligand–receptor-mediated multicellular signalling in human , 2015, Nature Communications.

[52]  Christian A. Rees,et al.  Molecular portraits of human breast tumours , 2000, Nature.

[53]  D. Fearon,et al.  Fibroblastic reticular cells of the lymph node are required for retention of resting but not activated CD8+ T cells , 2014, Proceedings of the National Academy of Sciences.

[54]  K. Sugamura,et al.  Therapeutic targeting of the effector T-cell co-stimulatory molecule OX40 , 2004, Nature Reviews Immunology.

[55]  Karin Jirström,et al.  Leukocyte complexity predicts breast cancer survival and functionally regulates response to chemotherapy. , 2011, Cancer discovery.

[56]  V. Soumelis,et al.  Human inflammatory dendritic cells induce Th17 cell differentiation. , 2013, Immunity.

[57]  S. Leung,et al.  CD8+ lymphocyte infiltration is an independent favorable prognostic indicator in basal-like breast cancer , 2012, Breast Cancer Research.

[58]  G. Freeman,et al.  Engagement of the Pd-1 Immunoinhibitory Receptor by a Novel B7 Family Member Leads to Negative Regulation of Lymphocyte Activation , 2000, The Journal of experimental medicine.

[59]  Mark W. Kieran,et al.  Identification of fibroblast heterogeneity in the tumor microenvironment , 2006, Cancer biology & therapy.

[60]  Ricardo Garcia,et al.  Biomechanical Remodeling of the Microenvironment by Stromal Caveolin-1 Favors Tumor Invasion and Metastasis , 2011, Cell.

[61]  E. Puré,et al.  Fibroblast activation protein expression by stromal cells and tumor-associated macrophages in human breast cancer. , 2013, Human pathology.

[62]  E. Barillot,et al.  Atlas of Cancer Signalling Network: a systems biology resource for integrative analysis of cancer data with Google Maps , 2015, Oncogenesis.

[63]  P. Hein,et al.  Carcinoma-associated fibroblasts stimulate tumor progression of initiated human epithelium , 2000, Breast Cancer Research.

[64]  J. Bergh,et al.  High expression of stromal PDGFRβ is associated with reduced benefit of tamoxifen in breast cancer , 2016, The journal of pathology. Clinical research.

[65]  Rameen Beroukhim,et al.  Molecular characterization of the tumor microenvironment in breast cancer. , 2004, Cancer cell.

[66]  Michael C. Ostrowski,et al.  Stromal PDGFR-α Activation Enhances Matrix Stiffness, Impedes Mammary Ductal Development, and Accelerates Tumor Growth , 2017, Neoplasia.

[67]  Z. Trajanoski,et al.  Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer. , 2013, Immunity.

[68]  B. Salomon,et al.  Suppressive activity of human regulatory T cells is maintained in the presence of TNF , 2016, Nature Medicine.